In conclusion, we developed a novel reporter gene-based MRI monitoring system for the detection of the malignant transformation of stem cells by modifying the genetic reporter FTH1 to be under the control of the tumor-specific promoter PEG3. Here, FTH1 is linked to neoplasm.